<html>
<head>PUBMED IDs for FXYD1</head>
<body bgcolor='#C5F0F2'><h1>FXYD1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/12657562/'>Phospholemman expression in extraglomerular mesangium and afferent arteriole of the juxtaglomerular apparatus.</a> March 27  2003<br><a href='https://pubmed.ncbi.nlm.nih.gov/16288923/'>Correlation of gene and protein structures in the FXYD family proteins.</a> November 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/16288911/'>Microarray analysis to evaluate different animal models for human heart failure.</a> November 18  2005<br><a href='https://pubmed.ncbi.nlm.nih.gov/17050615/'>Multiplicity of expression of FXYD proteins in mammalian cells: dynamic exchange of phospholemman and gamma-subunit in response to stress.</a> October 20  2006<br><a href='https://pubmed.ncbi.nlm.nih.gov/17309881/'>FXYD1 is an MeCP2 target gene overexpressed in the brains of Rett syndrome patients and Mecp2-null mice.</a> February 21  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18000745/'>Structures of the FXYD regulatory proteins in lipid micelles and membranes.</a> November 15  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/19879113/'>Differential cellular expression of FXYD1 (phospholemman) and FXYD2 (gamma subunit of Na, K-ATPase) in normal human tissues: a study using high density human tissue microarrays.</a> May 1  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/19879111/'>Association of promoter variants of human dopamine transporter gene with schizophrenia in Han Chinese.</a> February 25  2009<br><a href='https://pubmed.ncbi.nlm.nih.gov/20090424/'>Molecular remodeling of ion channels, exchangers and pumps in atrial and ventricular myocytes in ischemic cardiomyopathy.</a> November 9  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21449573/'>Phospholemman (FXYD1) raises the affinity of the human α1β1 isoform of Na,K-ATPase for Na ions.</a> July 13  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/21957166/'>Protein kinase Cα activity is important for contraction-induced FXYD1 phosphorylation in skeletal muscle.</a> February 15  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/22535957/'>Intracellular trafficking of FXYD1 (phospholemman) and FXYD7 proteins in Xenopus oocytes and mammalian cells.</a> August 25  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23224879/'>Coordinated regulation of cardiac Na(+)/Ca (2+) exchanger and Na (+)-K (+)-ATPase by phospholemman (FXYD1).</a> March 15  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23359667/'>Fibre type-specific change in FXYD1 phosphorylation during acute intense exercise in humans.</a> August 31  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/23430748/'>Neutral phospholipids stimulate Na,K-ATPase activity: a specific lipid-protein interaction.</a> June 1  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/24039836/'>Downregulation of miR-151-5p contributes to increased susceptibility to arrhythmogenesis during myocardial infarction with estrogen deprivation.</a> June 16  2013<br><a href='https://pubmed.ncbi.nlm.nih.gov/25051342/'>G-quadruplex formation of FXYD1 pre-mRNA indicates the possibility of regulating expression of its protein product.</a> November 5  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/26410457/'>FXYD1 negatively regulates Na(+)/K(+)-ATPase activity in lung alveolar epithelial cells.</a> September 23  2015<br><a href='https://pubmed.ncbi.nlm.nih.gov/26791827/'>Intensive training and reduced volume increases muscle FXYD1 expression and phosphorylation at rest and during exercise in athletes.</a> August 9  2016<br></body></html>
